Cargando…
Comprehensive analysis reveals TSEN54 as a robust prognosis biomarker and promising immune-related therapeutic target for hepatocellular carcinoma
Background: Hepatocellular carcinoma represents the most common primary malignancy of all liver cancer types and its prognosis is usually unsatisfactory. TSEN54 encodes a protein constituting a subunit of the tRNA splicing endonuclease heterotetramer. Previous researches concentrated on the contribu...
Autores principales: | Fu, Bidong, Zhou, Minqin, Song, Gelin, Zeng, Hong, Gong, Yiyang, Jiang, Yike, Ke, Yun, Huang, Da, Peng, Hong, Li, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120902/ https://www.ncbi.nlm.nih.gov/pubmed/37059591 http://dx.doi.org/10.18632/aging.204645 |
Ejemplares similares
-
TSEN54 missense variant in Standard Schnauzers with leukodystrophy
por: Störk, Theresa, et al.
Publicado: (2019) -
ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
por: Zhen, Jing, et al.
Publicado: (2022) -
Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022) -
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m(6)A modification, and drug susceptibility
por: Ding, Yongqi, et al.
Publicado: (2023) -
Identification of Alternative Variants and Insertion of the Novel Polymorphic AluYl17 in TSEN54 Gene during Primate Evolution
por: Lee, Ja-Rang, et al.
Publicado: (2016)